Why do so many phase III trials fail
59:17
Risk-Based Fraud Detection: How Centralized Monitoring Can Boost Data Quality
1:02:06
Does Real World Evidence have a role in Precision Oncology
1:00:56
GPC - A novel statistical method for outcome analysis & reporting of prioritized composite endpoints
1:02:39
Assessing treatment efficacy in early-phase oncology trials
2:57:36
Excel to Power BI [Full Course] 📊
1:01:05
Webinar: The Benefit-Risk assessment of new treatments: The Health Technology Assessment process
55:31
WEBINAR: The Added Value of Biostatistics Driven Randomization and Trial Supply Management System
57:08